Yuanyuan Cao

机构：China Pharmaceutical University, Wuxi Municipal Product Quality Supervision and Inspection Institute, Foshan Maternity and Child Health Care Hospital, Wuxi Institute of Technology · ORCID：0009-0001-3060-1435

发表论文 13 篇 · 总被引 139 次 · h-index 6

代表论文

• Laminins in tumor-derived exosomes upregulated by ETS1 reprogram omental macrophages to promote omental metastasis of ovarian cancer (2022 · Cell Death and Disease · 被引 49)
• Emerging Violet Phosphorus Nanomaterial for Biomedical Applications (2025 · Advanced Healthcare Materials · 被引 22)
• Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside (2024 · Applied Materials Today · 被引 21)
• FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer (2024 · Cell Death and Disease · 被引 19)
• One-stone-three-birds strategy: a graphdiyne oxide nanosheet-involved drug-formed immune-boosting hydrogel with dual responsivity for triple-modal cancer immunotherapy (2025 · Materials Today · 被引 7)
• Effect of Rectus Sheath Block on Postoperative Quality of Recovery After Transabdominal Midline Gynecological Surgery: A Randomized Controlled Trial (2024 · Journal of Pain Research · 被引 7)